In this upbeat interview, CEO Sara Barrington of Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through: 00:00 Reminder of Verici’s core USPs and technological lead 03:40 Update on commercial rollout 10:30 Market opportunity 16:05 £8.75m fund raise & cashflow breakeven 21:40 Other 2 diagnostics and product/service categories 33:05 Closing remarks
